Zhefang Wang
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 2
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 3
-
- RNA modifications and cancer 5
- Extracellular vesicles in disease 3
- Epigenetics and DNA Methylation 3
- Heme Oxygenase-1 and Carbon Monoxide 2
-
- Ferroptosis and cancer prognosis 2
-
- Cancer Research and Treatments 2
- Co-authors
- Christiane J. BrunsYue ZhaoQiongzhu DongChenghui ZhouJiangang ZhaoLun–Xiu QinPeter J. NelsonDai Li
- Journals
- Cellular and Molecular Life Sciences (1 paper)Signal Transduction and Targeted Therapy (1 paper)Seminars in Cancer Biology (2 papers)
- Partner nations
- GermanyChinaUnited States
In The Last Decade
Zhefang Wang
17 papers receiving 904 citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Cancer Research 422
- Oncology 335
- Molecular Biology 535
- Immunology 149
- Pulmonary and Respiratory Medicine 191
Countries citing papers authored by Zhefang Wang
This map shows the geographic impact of Zhefang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhefang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhefang Wang more than expected).
Fields of papers citing papers by Zhefang Wang
This network shows the impact of papers produced by Zhefang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhefang Wang. The network helps show where Zhefang Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhefang Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2021 | 20 | |
| 5 | 2021 | 16 | |
| 6 | The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectivesbreakdown → | 2021 | 220 |
| 7 | 2021 | 132 | |
| 8 | 2021 | 12 | |
| 9 | 2020 | 2 | |
| 10 | 2020 | 38 | |
| 11 | 2020 | 136 | |
| 12 | 2019 | 34 | |
| 13 | 2019 | 1 | |
| 14 | 2019 | 115 | |
| 15 | 2018 | 99 | |
| 16 | 2018 | 8 | |
| 17 | 2016 | 7 | |
| 18 | 2015 | 64 | |
| 19 | [Present status of treatment in peritoneal metastasis of gastric cancer]. | 2015 | 3 |
About Zhefang Wang
Zhefang Wang is a scholar working on Cancer Research, Biotechnology and Immunology, having authored 19 papers that have together received 908 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Extracellular vesicles in disease (3 papers), Epigenetics and DNA Methylation (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Cancer Research and Treatments (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Ferroptosis and cancer prognosis (2 papers) and Heme Oxygenase-1 and Carbon Monoxide (2 papers). The work is most often cited by research in Cancer Research (422 citations), Oncology (335 citations) and Molecular Biology (535 citations). Zhefang Wang has collaborated with scholars based in Germany, China and United States. Frequent co-authors include Christiane J. Bruns, Yue Zhao, Qiongzhu Dong, Chenghui Zhou, Jiangang Zhao, Lun–Xiu Qin, Peter J. Nelson, Dai Li, Ningbo Fan and Jie Qin. Their work appears in journals such as Cellular and Molecular Life Sciences, Signal Transduction and Targeted Therapy and Seminars in Cancer Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.